title: The effect of exogenous apelin on the secretion of pancreatic juice in anaesthetized rats.
abstract: Apelin is known to stimulate cholecystokinin (CCK) and inhibit insulin release, however the mechanisms on pancreatic secretion remain unclear. The present study aimed to determine the expression of apelin and apelin receptor in the pancreas by immunofluorescence studies and the effect of exogenous apelin on the secretion of pancreatic juice in anesthetized rats. Pancreatic-biliary juice (P-BJ) was collected from Wistar rats treated with apelin (10, 20 and 50 nmol/kg b.w., boluses given every 30 min intravenously or intraduodenaly). The same apelin doses were administered to rats subjected to intraduodenal tarazapide, capsaicin or vagotomy. Pancreatic blood flow was measured by a laser doppler flowmeter. Direct effects of apelin were tested on dispersed acinar cells. Apelin receptor was expressed on acinar cells, pancreatic duct and islets cells, whereas apelin in pancreatic acini, but not in the islets. Intravenous apelin decreased P-BJ volume, protein and trypsin outputs in a dose-dependent manner. In contrast, intraduodenal apelin stimulated P-BJ secretion. Pharmacological block of mucosal CCK(1) receptor by tarazepide, vagotomy and capsaicin pretreatment abolished the effects of intravenous and intraduodenal apelin on P-BJ volume, protein and tryspin outputs. Apelin decreased the pancreatic blood flow. Apelin at 10(-6) M increased the release of amylase from non-stimulated and CCK-8-stimulated acinar cells. In conclusion, apelin can affect the exocrine pancreas through a complex mechanism involving local blood flow regulation and is driven by vagal nerves.
authors.affiliation: Department of Biochemistry and Animal Physiology, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Poland.
authors.forename: M
authors.initials: M
authors.lastname: Kapica
authors.forename: A
authors.initials: A
authors.lastname: Jankowska
authors.forename: H
authors.initials: H
authors.lastname: Antushevich
authors.forename: P
authors.initials: P
authors.lastname: Pietrzak
authors.forename: J B
authors.initials: JB
authors.lastname: Bierla
authors.forename: A
authors.initials: A
authors.lastname: Dembinski
authors.forename: R
authors.initials: R
authors.lastname: Zabielski
mesh_terms: D061354:Acinar Cells / Q000187:drug effects / Q000378:metabolism; D000681:Amylases / Q000378:metabolism; D000818:Animals; D000073861:Apelin; D000075244:Apelin Receptors; D002766:Cholecystokinin / Q000378:metabolism; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism / Q000494:pharmacology*; D007515:Islets of Langerhans / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D046790:Pancreas, Exocrine / Q000187:drug effects* / Q000378:metabolism; D010183:Pancreatic Ducts / Q000098:blood supply / Q000187:drug effects / Q000378:metabolism*; D010189:Pancreatic Juice / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects; D012844:Sincalide / Q000378:metabolism; D014630:Vagus Nerve / Q000187:drug effects / Q000378:metabolism
chemical_list: D000073861:Apelin; D000075244:Apelin Receptors; C498579:Apln protein, rat; C491284:Aplnr protein, rat; D036341:Intercellular Signaling Peptides and Proteins; D043562:Receptors, G-Protein-Coupled; D002766:Cholecystokinin; D000681:Amylases; D012844:Sincalide